BCAL Diagnostics LimitedASX: BDX

Bioshares Conference Investor Presentation

· Issued by BCAL Diagnostics Limited via ASX

Filed with ASX ·

BCAL: The Early Detection Company Anne-Louise Arnett Chief Executive Officer (ASX: BDX) 6 th August 2026 T14 | Session 3: Diagnostics Feature BCAL Diagnostics | 20th Bioshares Biotech Summit 2026 Who is BCAL BCAL Diagnostics | 20th Bioshares Biotech Summit 2026 3 Experienced...

View Attachment

6ix hasn’t read this filing yet.

BCAL Diagnostics Limited on 6ix

In the deck

Story so far

Earlier from BCAL Diagnostics

Later from BCAL Diagnostics

All BCAL Diagnostics news releases